{"nct_id":"NCT00343486","title":"Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms","status":"COMPLETED","status_verified_date":"2009-05","start_date":"2006-05","start_date_type":null,"primary_completion_date":null,"primary_completion_date_type":null,"completion_date":null,"completion_date_type":null,"phases":["PHASE2"],"tickers":["GSK"]}